EUVIMEDEUVIMED entdecken
Crossref

Association of Serum Ferritin Levels with Disease Severity in NonAlcoholic Fatty Liver Disease

Madhu Sharma, Bushra Fiza, Bhavana Singha, Kavita Sharma, Shilpa Dhameja

International Journal of Drug Delivery Technology · 16.11.2026 · 16 (80s)

DOI: 10.25258/ijddt.16.80s.68 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.11.2026. Verfasst von Madhu Sharma und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease worldwide and is closely associated with metabolic syndrome. Serum ferritin, an acute-phase reactant and marker of iron stores, is frequently elevated in NAFLD patients.

Objective

To evaluate the association between serum ferritin levels and disease severity in patients with NAFLD. Materials and Methods: This observational study included 50 patients diagnosed with NAFLD based on clinical, biochemical, and ultrasonographic findings. Serum ferritin levels were measured and correlated with liver enzymes, metabolic parameters and NAFLD severity grading. Disease severity was assessed using liver function tests, ultrasonography grading and non-invasive fibrosis markers. Statistical analysis was performed to determine the association between serum ferritin levels and NAFLD severity.

Results

The serum ferritin levels in the non-alcoholic fatty liver disease group were significantly higher than those without non-alcoholic fatty liver disease group and levels were elevated in patients with moderate to severe NAFLD compared to those with mild disease. Serum ferritin levels were significantly associated with the risk of non-alcoholic fatty liver disease in both men and women. Ferritin showed a positive correlation with alanine aminotransferase (ALT), aspartate aminotransferase (AST) and body mass index (BMI). Higher ferritin levels were associated with increased hepatic inflammation and fibrosis risk.

Conclusion

Serum ferritin levels were higher in patients with non-alcoholic fatty liver disease than in those without non-alcoholic fatty liver disease and were associated with the risk of non-alcoholic fatty liver disease in both men and women and may serve as a useful non-invasive biomarker for assessing hepatic inflammation and fibrosis progression.

Zitieren

APA

Sharma, M., Fiza, B., Singha, B., Sharma, K., & Dhameja, S. (2026). Association of Serum Ferritin Levels with Disease Severity in NonAlcoholic Fatty Liver Disease. International Journal of Drug Delivery Technology, 16(80s). https://doi.org/10.25258/ijddt.16.80s.68

Vancouver

Sharma M, Fiza B, Singha B, Sharma K, Dhameja S. Association of Serum Ferritin Levels with Disease Severity in NonAlcoholic Fatty Liver Disease. International Journal of Drug Delivery Technology. 2026;16(80s). doi:10.25258/ijddt.16.80s.68

BibTeX
@article{Sharma2026,
  author = {Sharma, Madhu and Fiza, Bushra and Singha, Bhavana and Sharma, Kavita and Dhameja, Shilpa},
  title = {Association of Serum Ferritin Levels with Disease Severity in NonAlcoholic Fatty Liver Disease},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {80s},
  doi = {10.25258/ijddt.16.80s.68}
}
Kostenlos starten →